Since IL6 is a pro-inflammatory cytokine known to promote cancer metastasis and induces PD-1 expression in activated T cells, blocking IL6 pathway may reduce tumor immune escape in TME and enhance anticancer immunity (44). Here, IL6 is linked to neoplasm.